Aarti Pharmalabs (AARTIPHARM) Share Price hits fresh 52-week high; stock trades at Rs 988

Aarti Pharmalabs Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,001.55 and last traded at Rs 988, up 1.51% from the previous close of Rs 973.3. Aarti Pharmalabs Ltd. (AARTIPHARM) now carries a market capitalisation of Rs 8,288.13 crore, placing Aarti Pharmalabs Share Price firmly in today’s stock news flow. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.

The move matters because Aarti Pharmalabs Share Price is now trading just below the day high after opening at Rs 991.55 and moving between Rs 983.05 and Rs 1,001.55 during the session. For readers tracking Aarti Pharmalabs Share Price Today, the key question is not only where the stock traded, but what the latest fundamentals and sector valuation say about the current setup. Univest data also shows a revenue figure of Rs 535.8 crore for Jun 2026, which adds context to the Aarti Pharmalabs Share Price story without changing the fact that the fresh high is a market-price event first.

Aarti Pharmalabs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 988
Previous Close	Rs 973.3
Today's Move	+Rs 14.7 (+1.51%)
Open	Rs 991.55
High	Rs 1,001.55
Low	Rs 983.05
Market Capitalisation	Rs 8,288.13 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 988 versus the previous close of Rs 973.3, a rise of 1.51%. The stock opened at Rs 991.55, reached a high of Rs 1,001.55 and touched a low of Rs 983.05.

Aarti Pharmalabs Share Price Today reflects a day move of Rs 14.7 over the previous close, or 1.51%, with the stock last trading at Rs 988 after touching Rs 1,001.55. The open was Rs 991.55 and the day low was Rs 983.05, so the price stayed within a relatively tight band around the fresh 52-week high. That makes Aarti Pharmalabs Share Price a clear one-year high event for the market to note, even though no prior 52-week high is used here as a comparison reference.

For Aarti Pharmalabs Share Price, the immediate read is simple: the stock made a fresh yearly high, and the latest price remains close to that level rather than far away from it. Aarti Pharmalabs Share Price also matters because the session range itself shows where the market is trading right now. Readers following Aarti Pharmalabs Share Price Live can see that Rs 1,001.55 is the highest trade recorded in this event, while Rs 988 is the latest quote available in the same move. That is the core of the price action and the key bridge into Aarti Pharmalabs Share Price valuation.

Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 8,288.13 crore
P/E Ratio	41.41x
P/B Ratio	4.03x
ROE	8.5%
ROCE	10.77%
EPS	Rs 23.51
Book Value Per Share	Rs 241.54
Dividend Yield	0.36%

Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 41.41x, P/B 4.03x, ROE 8.5%, ROCE 10.77%. Read together, these ratios describe the company's position rather than a recommendation.

Aarti Pharmalabs Ltd. has a market capitalisation of Rs 8,288.13 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.41x, P/B at 4.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.41x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.41x
Benchmark Median P/E	32.41x
Benchmark Average P/E	49.51x
Benchmark P/E Range	3.4x to 699.02x
Company P/B Ratio	4.03x
Benchmark Median P/B	2.89x
Company ROE	8.5%
Benchmark Median ROE	11.74%
Company ROCE	10.77%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 8,288.13 crore
Benchmark Median Market Cap	Rs 773.14 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 41.41x, which is above the benchmark median of 32.41x, a difference of +27.77%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.74%, a difference of -27.6%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.63%, a difference of -20.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Supriya Lifescience Ltd.	SUPRIYA	7,922.73	39.94	6.48	19.06	25.3
Bliss GVS Pharma Ltd.	BLISSGVS	7,842.94	55.44	6.12	12.11	17.4
Sanofi Consumer Healthcare India Ltd.	SANOFICONR	8,902.83	33.47	25.59	73.2	98.11
Innova Captab Ltd.	INNOVACAP	7,275.01	46.59	6.42	13.75	15.04
Procter & Gamble Health Ltd.	PGHL	9,489.04	26.59	15.41	62.18	84.86

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 41.41x compared with the displayed peer median of 39.94x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 8.5% compares with a peer median of 19.06% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 25.3%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 8,288.13 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Aarti Pharmalabs

• Aarti Pharmalabs Share Price touched a fresh 52-week high of Rs 1,001.55 and last traded at Rs 988.
• The stock is up 1.51% from the previous close of Rs 973.3.
• Aarti Pharmalabs Share Price carries a market capitalisation of Rs 8,288.13 crore.
• The P/E ratio is 41.41 and the P/B ratio is 4.03.
• ROE is 8.5% and ROCE is 10.77%, both below the industry median.

About Aarti Pharmalabs

Aarti Pharmalabs Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Aarti Pharmalabs Share Price is watched because the company is listed on NSE and BSE under AARTIPHARM, and the latest figures place its market capitalisation at Rs 8,288.13 crore. The Jun 2026 revenue figure of Rs 535.8 crore gives a recent business reference point for Aarti Pharmalabs Share Price analysis, while EPS of Rs 23.51 and book value of Rs 241.54 provide additional balance-sheet and earnings context.

For Aarti Pharmalabs Share Price Today, the company remains part of a broader pharmaceutical peer set where valuation and return ratios vary meaningfully. That makes Aarti Pharmalabs Stock News useful for readers who want to track the stock price alongside company financials, not just the daily move. Univest keeps Aarti Pharmalabs Share Price, fundamentals and market cap in one view for quick monitoring.

Frequently Asked Questions

Why did Aarti Pharmalabs Share Price hit a fresh 52-week high?

Ans. According to latest Univest data, Aarti Pharmalabs Share Price touched Rs 1,001.55, a fresh 52-week high. The data confirms the event, but it does not establish a company-specific catalyst for the move.

What is Aarti Pharmalabs Share Price today?

Ans. Aarti Pharmalabs Share Price last traded at Rs 988 after rising Rs 14.7, or 1.51%, from the previous close of Rs 973.3. That keeps the stock near its fresh yearly high.

What was the 52-week high for Aarti Pharmalabs Share Price?

Ans. The fresh 52-week high for Aarti Pharmalabs Share Price was Rs 1,001.55. The stock later traded at Rs 988, so the latest quote remained below that peak during the session.

How does Aarti Pharmalabs Share Price compare with sector valuation?

Ans. Aarti Pharmalabs Share Price has a P/E of 41.41 versus the industry median of 32.41 and a P/B of 4.03 versus the median of 2.89. That places it above median on both measures.

Is Aarti Pharmalabs Share Price supported by profitability ratios?

Ans. Aarti Pharmalabs Share Price comes with ROE of 8.5% and ROCE of 10.77%, both below the industry medians of 11.74% and 13.63%. EPS stands at Rs 23.51 and book value at Rs 241.54.

What market cap does Aarti Pharmalabs Share Price have?

Ans. Aarti Pharmalabs Share Price is backed by a market capitalisation of Rs 8,288.13 crore. That places the company within a broad peer set where several comparable names trade in a similar market-cap range.

What revenue figure is available for Aarti Pharmalabs?

Ans. The latest available revenue figure for Aarti Pharmalabs is Rs 535.8 crore for Jun 2026. That gives context to Aarti Pharmalabs Share Price, although it should be read alongside valuation and return ratios.

Should investors track Aarti Pharmalabs Share Price on Univest?

Ans. Yes. Univest lets readers track Aarti Pharmalabs Share Price with live price, market cap, valuation ratios and 52-week levels in one place, which is useful after a fresh yearly high event.

Track Aarti Pharmalabs Share Price on Univest

Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Aarti Pharmalabs Share Price on Univest for live price updates, market cap, valuation ratios, 52-week levels and company financials. The same page also helps readers follow Aarti Pharmalabs Share Price Today alongside sector context and peer comparison in one place.